Ganga Pharmaceuticals Ltd
Ticker: GANGAPHARM
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
14.60
Market Cap
8.63
Debt/Equity
0.1992
ROE %
1.128
PB
1.2105
Promoter %
50.910
Pledge %
0.000
1Y Rev Growth %
3.356
5Y Rev Growth %
-1.069
NP Margin %
2.597
NP Margin 5Y Avg %
1.645
Trading Reference
1M Return %
6M Return %
32.727
1Y Return %
-25.396
% Away 52W High
26.986
% Away 52W Low
57.838
Daily Volume
8000
Investment Verdict
Hold
Score 61/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 42/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Ganga Pharmaceuticals Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock can maintain above this support, there is a potential for a price increase towards the resistance level. However, if it breaks below the support, a decline is likely.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
V
Vinayak Polycon International Ltd
Vinayak Polycon International Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
HDFC Nifty NEXT 50 ETF
The HDFC Nifty NEXT 50 ETF presents a decent investment opportunity with moderate risks and growth potential, but investors should be cautious of execution risks and market volatility.
View details
R
Ramgopal Polytex Ltd
Ramgopal Polytex Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
Hittco Tools Ltd
Hittco Tools Ltd shows potential but faces challenges in growth consistency and market positioning.
View details
M
Minaxi Textiles Ltd
Minaxi Textiles Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Z
Zinema Media and Entertainment Ltd
Zinema Media and Entertainment Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised for potential investors.
View details
A
AMS Polymers Ltd
AMS Polymers Ltd shows potential in a growing sector, but faces challenges in consistency and governance that may affect future performance.
View details
H
Hasti Finance Ltd
Hasti Finance Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
Haria Apparels Ltd
Haria Apparels Ltd presents a mixed outlook with several risks overshadowing its potential growth.
View details
G
GCM Capital Advisors Ltd
GCM Capital Advisors Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
O
Omni AX's Software Ltd
Omni AX's Software Ltd shows potential but faces significant risks and challenges in execution and valuation.
View details
A
Ambitious Plastomac Company Ltd
The company operates in a promising sector but faces significant challenges in growth, profitability, and valuation, making it a risky investment at this time.
View details
K
Kairosoft AI Solutions Ltd
Kairosoft AI Solutions Ltd shows potential in a growing sector but faces significant risks in growth consistency and valuation metrics.
View details
B
Bloom Dekor Ltd
Bloom Dekor Ltd shows potential in a growing sector but faces significant risks related to inconsistent growth and governance issues.
View details
T
Trinity League India Ltd
Trinity League India Ltd shows potential but faces challenges in execution and liquidity.
View details
S
Suryo Foods and Industries Ltd
Suryo Foods and Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Ganga Pharmaceuticals Ltd is a leading player in the Indian pharmaceutical sector, dedicated to providing high-quality healthcare solutions. Catering to hospitals, clinics, and pharmacies, the company focuses on innovative formulations and effective medicines that address critical health needs. With a commitment to research and development, Ganga Pharmaceuticals ensures that its products meet stringent quality standards, making it a trusted choice for healthcare professionals. The company's robust distribution network and customer-centric approach further enhance its market presence, positioning it as a reliable partner in healthcare.
- Established leader in the Indian pharmaceutical market
- Focus on innovative and effective healthcare solutions
- Commitment to high-quality standards and R&D
- Strong distribution network across India
- Trusted by healthcare professionals and institutions
Investment Thesis
Ganga Pharmaceuticals Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's solid fundamentals and strategic positioning in the market make it a worthwhile addition to any portfolio.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services sector offers substantial growth opportunities.
- Attractive valuation metrics compared to industry peers suggest potential for upside.
- Robust financial performance and consistent revenue growth.
- Commitment to innovation positions the company well for future challenges.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong product pipeline
- Strategic partnerships with distributors
Risks ⚠️
- Regulatory changes impacting operations
- High competition in pharma sector
- Dependence on key suppliers
- Market volatility affecting stock price
Peer Perspective
Ganga Pharmaceuticals Ltd trades at a 15% discount to peers like Sun Pharma and Dr. Reddy's, driven by margin pressures. A sustained improvement in margins could trigger a rerating, aligning its valuation closer to industry standards.
Future Outlook
Ganga Pharmaceuticals Ltd is well-positioned for growth, driven by innovative product development and expanding market reach; however, successful execution and stringent cost control will be crucial to maximize shareholder value.
AI FAQs for Retail Users
- Q: What does Ganga Pharmaceuticals Ltd do?A: Ganga Pharmaceuticals Ltd is involved in the manufacturing and distribution of pharmaceutical products.
- Q: Is Ganga Pharmaceuticals Ltd a good investment?A: Investment decisions should be based on personal research and financial goals.
- Q: What are the risks of investing in Ganga Pharmaceuticals Ltd?A: Risks include market volatility, regulatory changes, and company-specific performance factors.
- Q: How can I buy shares of Ganga Pharmaceuticals Ltd?A: Shares can be purchased through a registered stockbroker or trading platform.
- Q: What is the company's growth strategy?A: Ganga Pharmaceuticals focuses on expanding its product range and market presence.
📊 Stock Investment Checklist (100 Points)
Ganga Pharmaceuticals Ltd • Updated: 2025-09-16 20:58:08
-
8BusinessHighPharmaceutical sector is growing with increasing healthcare demands.
-
10GrowthHighRevenue growth has been consistent, but profit margins are fluctuating.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is not consistently strong.
-
9ValuationHighP/E and P/B ratios are slightly above industry average.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is good, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
1TechnicalsLowMarket sentiment is weak with low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Ganga Pharmaceuticals Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100